The June issue of the Global Fund to Fight AIDS, Tuberculosis and Malaria’s email newsletter, the “Global Fund News Flash,” was released on Thursday. The issue highlights the Global Fund’s “Better Grants for Increased Impact” project, discusses malaria in Madagascar, notes the launch of the (RED) RUSH TO ZERO campaign, profiles Indonesia Fund Portfolio Manager Gail Steckley, and features a new cell phone application from Charity Miles, which “enables people to earn money for charity simply by walking, running or biking” (6/7).
During a live webcast discussing recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria, “[p]anelists discussed the fund’s new strategy and what this strategy means for the global fight against these three diseases,” GlobalPost’s “Global Pulse” blog reports. J. Stephen Morrison, senior vice president and director of the Global Health Policy Center at the Center for Strategic and International Studies, noted the Global Fund’s new general manager, Gabriel Jaramillo, had moved quickly in focusing on restructuring and realigning the fund, according to the blog. Todd Summers, independent consultant and chair of the Strategy, Investment & Impact Committee at the Global Fund, said, “Now we see lots of opportunity to really make a big difference and change forever the trajectory” of the epidemics, “Global Pulse” notes.
The Kaiser Family Foundation (KFF) on Wednesday “held a live, interactive webcast to examine recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria and the implications for U.S. global health policy,” the foundation reports on its webpage, where a video recording of the webcast is available. “A panel of experts discussed the Global Fund’s recent funding challenges and reorganization, how the U.S. and other donor nations are responding to these changes, and the future outlook for the Fund’s efforts to address HIV, TB, and malaria around the world,” KFF notes (6/13).
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 4 of its newsletter, the “Global Fund News Flash.” The issue features a commentary by Mireille Guigaz, a Global Fund Board member representing France, on the Global Fund’s work in Madagascar, and a piece examining “a Board decision last November that 55 percent of all funding for grant renewals should go to low-income countries,” among other stories (6/19).
Aidspan, an independent watchdog of the Global Fund, on Tuesday published Issue 187 of its “Global Fund Observer.” The issue includes an article on an Office of the Inspector General (OIG) report on its audit of eight Global Fund grants in Kenya; an article examining how reprogramming existing grants can improve their impact; and commentary from Bernard Rivers, executive director of Aidspan, about the Round 2 grants in Kenya (6/5).
The Center for Global Health Policy’s “Science Speaks” blog profiles Bernard Rivers, founder and executive director of Aidspan, a watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, who is leaving his position after 10 years. “He will not be running Aidspan anymore, but plans to continue to research and write about Global Fund issues,” the blog states. In the blog, Rivers discusses his motivation behind founding Aidspan and his hopes for the future of the Global Fund (Barton, 8/30).
“The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved 45 new two-year grants, from 37 countries, totaling $419.2 million, to fund essential prevention, treatment, and care services provided to the people affected by the three diseases,” according to a Global Fund press release. “Another 11 proposals worth a total of $91.2 million were sent back for revision, and are subject to a further independent technical review before they can be approved,” the press release adds, noting the grant approvals are part of the Transitional Funding Mechanism and “will bridge the financing of essential interventions until the next opportunity to apply for grants” (8/28). According to the U.N. News Centre, the Global Fund “has approved funding of $22.9 billion for more than 1,000 programs in 151 countries, and helped programs provide AIDS treatment for 3.6 million people, anti-tuberculosis treatment for 9.3 million people, and 270 million insecticide-treated nets for the prevention of malaria” (8/28).
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 193 of its “Global Fund Observer.” The issue features an article announcing the Global Fund’s Transitional Funding Mechanism (TFM) decisions; an article reporting the results of the TFM decisions by country; and an article about a new report from the Global Fund Board on challenges in grant implementation, among others (8/27).
“According to analysis led by Kanika Bahl and Pooja Shaw of Results for Development’s (R4D’s) Market Dynamics team, improved global incentives and information on cost-effectiveness could save the fight against malaria up to $630 million over the next five years and encourage manufacturers to produce better-performing nets,” Bahl, a managing director for R4D, and Shaw, a program officer in the Market Dynamics Practice at R4D, write in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog. “Using their central position in global [long-lasting insecticide-treated net (LLIN)] markets, donor institutions can introduce policy incentives to focus on cost-effectiveness and rationalize specifications so that suppliers can take advantage of economies of scale in production,” they continue, adding, “To implement these policies, global guidance on the performance of various nets is urgently needed, and this is where organizations such as the WHO can provide direction” (8/27).
The U.S. Government Accountability Office (GAO) recently released two reports on issues related to global health. In “Ensuring Drug Quality in Global Health Programs,” the agency writes, “Concerns have been raised about the potential for substandard drugs to enter the supply chains of global health programs,” and notes that it concluded, “U.S.-funded global health programs have put regulatory and policy requirements in place to help prevent procurement of substandard drugs” (8/1). In another report looking at the WHO, titled “Reform Agenda Developed, but U.S. Actions to Monitor Progress Could be Enhanced,” GAO found, “The United States has provided input into WHO’s reform agenda, particularly in the areas of transparency and accountability, but the Department of State’s (State) tool for assessing progress in the area of management reform could be enhanced” (7/23).